Modifi Biosciences Acquired by Merck
23 oct. 2024 07h05 HE
|
Modifi Biosciences
NEW HAVEN, Conn., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Modifi Biosciences, Inc. (“Modifi Biosciences”), a leader in the development of direct DNA modification enabled cancer therapeutics, today...
Modifi Bio Raises Additional $4.3 Million in Seed Funding
16 oct. 2023 07h00 HE
|
Modifi Biosciences
NEW HAVEN, Conn., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Modifi Biosciences, a leader in DNA modification as a novel approach to target cancer, today announced the closing of $4.3 million in a second...
Modifi Bio Announces Scientific Advisory Board
13 déc. 2022 08h30 HE
|
Modifi Biosciences
NEW HAVEN, Conn., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Modifi Biosciences, a leader in DNA modification as a novel approach to target cancer, today announced its Scientific Advisory Board, with the...
Modifi Bio Receives $2.4 Million Award from National Cancer Institute to Advance Innovative Precision Oncology Platform
25 oct. 2022 08h00 HE
|
Modifi Biosciences
NEW HAVEN, Conn., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Modifi Biosciences, a leader in direct DNA modification developing novel cancer therapeutics, has been selected by the National Cancer Institute...
Science Publication First to Describe Modifi Bio’s Novel Approach to Fight Cancer Cells with DNA Modification
28 juil. 2022 14h11 HE
|
Modifi Biosciences
NEW HAVEN, Conn., July 28, 2022 (GLOBE NEWSWIRE) -- Modifi Biosciences announced today that the journal Science has published a critical study validating the company’s novel oncology platform based...